Format

Send to

Choose Destination
See comment in PubMed Commons below
An Med Interna. 2002 Dec;19(12):640-3.

[Clinical benefits of tiotropium, a new anticholinergic bronchodilator].

[Article in Spanish]

Author information

1
Servicio de NeumologĂ­a, Hospital General Universitario de Guadalajara, C/Donantes de Sangre, s/n 19002 Guadalajara. jia01gu@nacom.es

Abstract

Bronchodilators are, at the present time, the mainstay of symptomatic therapy in patients with chronic obstructive pulmonary disease (COPD). Anticholinergics are the first steep in the clinical management of these patients although its short half life constitutes a serious limitation in patients with persistent symptoms. However, there have been some important developments on this area. Tiotropium bromide, used once daily shows several clinical advantages when it is compared with ipratropium bromide or with long acting beta-2 agonists. This suggests than tiotropium bromide could be in coming years one of the first options for the treatment of COPD.

PMID:
12593035
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center